NYU Langone Health has officially discontinued its Transgender Youth Health Program, ending access to puberty blockers, hormone therapies, and certain surgical interventions for patients under 18.

In a statement Tuesday, spokesperson Steve Ritea said the decision followed the departure of the program’s medical director and reflected “the current regulatory environment.” The program operated through Hassenfeld Children’s Hospital and primarily provided pharmaceutical treatments, though limited surgeries were available for older adolescents in select cases. Adult transgender services will continue through the hospital’s broader care network.

The closure comes amid escalating federal scrutiny. Since returning to office, President Donald Trump has issued executive actions aimed at restricting what his administration describes as irreversible medical interventions for minors. His executive order titled “Protecting Children from Chemical and Surgical Mutilation” directs federal agencies to curb support for such treatments.

The United States Department of Health and Human Services has also proposed rules that would make Medicare and Medicaid participation contingent on hospitals ceasing puberty blockers, hormone therapy, and surgical procedures for minors experiencing gender dysphoria. In fiscal year 2023, NYU Langone received more than $600 million in federal grants, underscoring the financial stakes for large hospital systems.

New York Attorney General Letitia James previously warned healthcare providers that denying services based on gender identity could violate state anti-discrimination laws. Manhattan Borough President Brad Hoylman-Sigal criticized the hospital’s decision, arguing institutions are being pressured into compliance by federal authorities.

NYU Langone joins other medical centers that have scaled back pediatric gender-related services in recent months, including Children’s National in Washington, D.C., and Children’s Hospital Colorado. While pediatric mental health services at NYU Langone will remain in place, the medical component of its youth program has been fully discontinued.

The dispute highlights an ongoing clash between federal policy shifts and state-level protections, as hospitals weigh regulatory compliance, funding considerations, and competing legal obligations.